Drug: |
Imatinib + AT13387 |
|||
---|---|---|---|---|
Trial: |
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
Duke University |
Principal Investigator: |
Richard Riedel |
---|---|
Contact: |
Anne Marie Peters 919-681-4768 annemarie.peters@duke.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Duke University Website: |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.